Dendrobium candidum Wall. ex Lindl. attenuates CCl4‑induced hepatic damage in imprinting control region mice

  • Authors:
    • Gui‑Jie Li
    • Peng Sun
    • Qiang Wang
    • Yu Qian
    • Kai Zhu
    • Xin Zhao
  • View Affiliations

  • Published online on: July 8, 2014     https://doi.org/10.3892/etm.2014.1834
  • Pages: 1015-1021
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to determine the preventive effect of the traditional Chinese medicine, Dendrobium candidum Wall ex Lindl. (D. candidum), on CCl4‑induced hepatic damage in mice. The CCl4‑induced hepatic damage mice were treated with D. candidum, and the serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), triglyceride (TG) and total cholesterol (TC) were determined. In addition, serum cytokine levels of interleukin (IL)‑6, IL‑12, tumor necrosis factor (TNF)‑α and interferon (IFN)‑γ were analyzed with kits, while liver tissues were analyzed using hematoxylin and eosin staining and reverse transcription polymerase chain reaction (RT-PCR). Furthermore, the contents of D. candidum were determined by nuclear magnetic resonance (NMR). D. candidum was demonstrated to successfully prevent hepatic damage in mice. The serum levels of AST, ALT and LDH were significantly decreased when the mice were treated with 200 and 400 mg/kg D. candidum, as compared with the control mice (P<0.05). The lowest enzymatic activities were exhibited in the 400 mg/kg D. candidum group, which produced similar results to the positive control drug, silymarin. In addition, in the 400 mg/kg D. candidum group, the highest levels of TG and TC were observed among the treated groups. D. candidum‑treated groups also demonstrated reduced levels of the serum proinflammatory cytokines, IL‑6, IL‑12, TNF‑α and IFN‑γ. The sections of liver tissue examined during histopathology in the high concentration 400 mg/kg D. candidum group recovered well from CCl4 damage; however, the sections in the 200 mg/kg D. candidum group revealed necrosis to a more serious degree. RT‑PCR analysis was conducted on inflammation‑associated genes, including nuclear factor (NF)‑κB, IκB‑α, inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)‑2, in the livers of the mice. The 400 mg/kg D. candidum group demonstrated significantly decreased mRNA expression levels of NF‑κB, iNOS and COX‑2, but an increased expression level of IκB‑α when compared with the CCl4‑treated control group. Furthermore, using NMR, 11 compounds were identified in the D. candidum leaf, whose functional contents may aid the preventive effect observed in the current study. Therefore, D. candidum may potentially contribute to the prevention of CCl4‑induced hepatic damage in vivo.
View Figures
View References

Related Articles

Journal Cover

September-2014
Volume 8 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li GJ, Sun P, Wang Q, Qian Y, Zhu K and Zhao X: Dendrobium candidum Wall. ex Lindl. attenuates CCl4‑induced hepatic damage in imprinting control region mice. Exp Ther Med 8: 1015-1021, 2014
APA
Li, G., Sun, P., Wang, Q., Qian, Y., Zhu, K., & Zhao, X. (2014). Dendrobium candidum Wall. ex Lindl. attenuates CCl4‑induced hepatic damage in imprinting control region mice. Experimental and Therapeutic Medicine, 8, 1015-1021. https://doi.org/10.3892/etm.2014.1834
MLA
Li, G., Sun, P., Wang, Q., Qian, Y., Zhu, K., Zhao, X."Dendrobium candidum Wall. ex Lindl. attenuates CCl4‑induced hepatic damage in imprinting control region mice". Experimental and Therapeutic Medicine 8.3 (2014): 1015-1021.
Chicago
Li, G., Sun, P., Wang, Q., Qian, Y., Zhu, K., Zhao, X."Dendrobium candidum Wall. ex Lindl. attenuates CCl4‑induced hepatic damage in imprinting control region mice". Experimental and Therapeutic Medicine 8, no. 3 (2014): 1015-1021. https://doi.org/10.3892/etm.2014.1834